Global Invasive Brain Monitoring Device Sales Market by Type (Electroencephalography (EEG) Devices, Magnetoencephalography (MEG) Devices, Transcranial Doppler (TCD) Devices, Intracranial Pressure (ICP) Monitors, Cerebral Oximeters, Magnetic Resonance Imaging (MRI) Devices, Computerized Tomography (CT) Devices, Positron Emission Tomography (PET) Devices, Sleep Monitoring Devices, Electromyography (EMG) Devices), By Application (Epilepsy, Dementia, Parkinson’s Disease, Huntington's Disease, Headache Disorders, Stroke, Others) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast To 2028
Up Market Research published a new report titled “Invasive Brain Monitoring Device Sales Market research report which is segmented by Types (Electroencephalography (EEG) Devices, Magnetoencephalography (MEG) Devices, Transcranial Doppler (TCD) Devices, Intracranial Pressure (ICP) Monitors, Cerebral Oximeters, Magnetic Resonance Imaging (MRI) Devices, Computerized Tomography (CT) Devices, Positron Emission Tomography (PET) Devices, Sleep Monitoring Devices, Electromyography (EMG) Devices), By Applications (Epilepsy, Dementia, Parkinson’s Disease, Huntington's Disease, Headache Disorders, Stroke, Others), By Players/Companies Natus Medical Inc (US), Nihon Kohden Corporation (Japan), Philips Healthcare (Netherlands), GE Healthcare (U.K.), Siemens Healthineers (Germany), Compumedics Ltd. (Australia), Electrical Geodesics Incorporated (US), Medtronic plc (Ireland), CAS Medical Systems, Inc (US), Advanced Brain Monitoring (US)”. As per the study the market is expected to grow at a CAGR of XX% in the forecast period.
Report Scope
| Report Attributes | Report Details |
| Report Title | Invasive Brain Monitoring Device Sales Market Research Report |
| By Type | Electroencephalography (EEG) Devices, Magnetoencephalography (MEG) Devices, Transcranial Doppler (TCD) Devices, Intracranial Pressure (ICP) Monitors, Cerebral Oximeters, Magnetic Resonance Imaging (MRI) Devices, Computerized Tomography (CT) Devices, Positron Emission Tomography (PET) Devices, Sleep Monitoring Devices, Electromyography (EMG) Devices |
| By Application | Epilepsy, Dementia, Parkinson’s Disease, Huntington's Disease, Headache Disorders, Stroke, Others |
| By Companies | Natus Medical Inc (US), Nihon Kohden Corporation (Japan), Philips Healthcare (Netherlands), GE Healthcare (U.K.), Siemens Healthineers (Germany), Compumedics Ltd. (Australia), Electrical Geodesics Incorporated (US), Medtronic plc (Ireland), CAS Medical Systems, Inc (US), Advanced Brain Monitoring (US) |
| Regions Covered | North America, Europe, APAC, Latin America, MEA |
| Base Year | 2020 |
| Historical Year | 2018 to 2019 (Data from 2010 can be provided as per availability) |
| Forecast Year | 2028 |
| Number of Pages | 236 |
| Number of Tables & Figures | 166 |
| Customization Available | Yes, the report can be customized as per your need. |
The report covers comprehensive data on emerging trends, market drivers, growth opportunities, and restraints that can change the market dynamics of the industry. It provides an in-depth analysis of the market segments which include products, applications, and competitor analysis.
Global Invasive Brain Monitoring Device Sales Market Report Segments:
The market is segmented by Type Electroencephalography (EEG) Devices, Magnetoencephalography (MEG) Devices, Transcranial Doppler (TCD) Devices, Intracranial Pressure (ICP) Monitors, Cerebral Oximeters, Magnetic Resonance Imaging (MRI) Devices, Computerized Tomography (CT) Devices, Positron Emission Tomography (PET) Devices, Sleep Monitoring Devices, Electromyography (EMG) Devices and By Application Epilepsy, Dementia, Parkinson’s Disease, Huntington's Disease, Headache Disorders, Stroke, Others.
Some of the companies that are profiled in this report are:
- Natus Medical Inc (US)
- Nihon Kohden Corporation (Japan)
- Philips Healthcare (Netherlands)
- GE Healthcare (U.K.)
- Siemens Healthineers (Germany)
- Compumedics Ltd. (Australia)
- Electrical Geodesics Incorporated (US)
- Medtronic plc (Ireland)
- CAS Medical Systems, Inc (US)
- Advanced Brain Monitoring (US)
Invasive Brain Monitoring Device Sales Market research report delivers a close watch on leading competitors with strategic analysis, micro and macro market trend and scenarios, pricing analysis and a holistic overview of the market situations in the forecast period. It is a professional and a detailed report focusing on primary and secondary drivers, market share, leading segments and geographical analysis. Further, key players, major collaborations, merger & acquisitions along with trending innovation and business policies are reviewed in the report.
Key Benefits for Industry Participants & Stakeholders:
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Invasive Brain Monitoring Device Sales Market
Overview of the regional outlook of the Invasive Brain Monitoring Device Sales Market:
Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa (MEA). North America region is further bifurcated into countries such as U.S., and Canada. The Europe region is further categorized into U.K., France, Germany, Italy, Spain, Russia, and Rest of Europe. Asia Pacific is further segmented into China, Japan, South Korea, India, Australia, South East Asia, and Rest of Asia Pacific. Latin America region is further segmented into Brazil, Mexico, and Rest of Latin America, and the MEA region is further divided into GCC, Turkey, South Africa, and Rest of MEA.
Highlights of The Invasive Brain Monitoring Device Sales Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of Invasive Brain Monitoring Device Sales Market.
- Historical data and forecast.
- Estimations for the forecast period 2028.
- Developments and trends in the market.
- By Type:
1. Electroencephalography (EEG) Devices
2. Magnetoencephalography (MEG) Devices
3. Transcranial Doppler (TCD) Devices
4. Intracranial Pressure (ICP) Monitors
5. Cerebral Oximeters
6. Magnetic Resonance Imaging (MRI) Devices
7. Computerized Tomography (CT) Devices
8. Positron Emission Tomography (PET) Devices
9. Sleep Monitoring Devices
10. Electromyography (EMG) Devices
7. By Application:1. Epilepsy
2. Dementia
3. Parkinson’s Disease
4. Huntington's Disease
5. Headache Disorders
6. Stroke
7. Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Invasive Brain Monitoring Device Sales Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2028.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
Reasons to Purchase the Invasive Brain Monitoring Device Sales Market Report:
- The report includes a plethora of information such as market dynamics scenario and opportunities during the forecast period
- Segments and sub-segments include quantitative, qualitative, value (USD Million,) and volume (Units Million) data.
- Regional, sub-regional, and country level data includes the demand and supply forces along with their influence on the market.
- The competitive landscape comprises share of key players, new developments, and strategies in the last three years.
- Comprehensive companies offering products, relevant financial information, recent developments, SWOT analysis, and strategies by these players.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Invasive Brain Monitoring Device Sales Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Invasive Brain Monitoring Device Sales Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Invasive Brain Monitoring Device Sales Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Invasive Brain Monitoring Device Sales Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Invasive Brain Monitoring Device Sales Market Size & Forecast, 2018-2028
4.5.1 Invasive Brain Monitoring Device Sales Market Size and Y-o-Y Growth
4.5.2 Invasive Brain Monitoring Device Sales Market Absolute $ Opportunity
Chapter 5 Global Invasive Brain Monitoring Device Sales Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Invasive Brain Monitoring Device Sales Market Size Forecast by Type
5.2.1 Electroencephalography (EEG) Devices
5.2.2 Magnetoencephalography (MEG) Devices
5.2.3 Transcranial Doppler (TCD) Devices
5.2.4 Intracranial Pressure (ICP) Monitors
5.2.5 Cerebral Oximeters
5.2.6 Magnetic Resonance Imaging (MRI) Devices
5.2.7 Computerized Tomography (CT) Devices
5.2.8 Positron Emission Tomography (PET) Devices
5.2.9 Sleep Monitoring Devices
5.2.10 Electromyography (EMG) Devices
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Invasive Brain Monitoring Device Sales Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Invasive Brain Monitoring Device Sales Market Size Forecast by Applications
6.2.1 Epilepsy
6.2.2 Dementia
6.2.3 Parkinson’s Disease
6.2.4 Huntington's Disease
6.2.5 Headache Disorders
6.2.6 Stroke
6.2.7 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Invasive Brain Monitoring Device Sales Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Invasive Brain Monitoring Device Sales Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Invasive Brain Monitoring Device Sales Analysis and Forecast
9.1 Introduction
9.2 North America Invasive Brain Monitoring Device Sales Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Invasive Brain Monitoring Device Sales Market Size Forecast by Type
9.6.1 Electroencephalography (EEG) Devices
9.6.2 Magnetoencephalography (MEG) Devices
9.6.3 Transcranial Doppler (TCD) Devices
9.6.4 Intracranial Pressure (ICP) Monitors
9.6.5 Cerebral Oximeters
9.6.6 Magnetic Resonance Imaging (MRI) Devices
9.6.7 Computerized Tomography (CT) Devices
9.6.8 Positron Emission Tomography (PET) Devices
9.6.9 Sleep Monitoring Devices
9.6.10 Electromyography (EMG) Devices
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Invasive Brain Monitoring Device Sales Market Size Forecast by Applications
9.10.1 Epilepsy
9.10.2 Dementia
9.10.3 Parkinson’s Disease
9.10.4 Huntington's Disease
9.10.5 Headache Disorders
9.10.6 Stroke
9.10.7 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Invasive Brain Monitoring Device Sales Analysis and Forecast
10.1 Introduction
10.2 Europe Invasive Brain Monitoring Device Sales Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Invasive Brain Monitoring Device Sales Market Size Forecast by Type
10.6.1 Electroencephalography (EEG) Devices
10.6.2 Magnetoencephalography (MEG) Devices
10.6.3 Transcranial Doppler (TCD) Devices
10.6.4 Intracranial Pressure (ICP) Monitors
10.6.5 Cerebral Oximeters
10.6.6 Magnetic Resonance Imaging (MRI) Devices
10.6.7 Computerized Tomography (CT) Devices
10.6.8 Positron Emission Tomography (PET) Devices
10.6.9 Sleep Monitoring Devices
10.6.10 Electromyography (EMG) Devices
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Invasive Brain Monitoring Device Sales Market Size Forecast by Applications
10.10.1 Epilepsy
10.10.2 Dementia
10.10.3 Parkinson’s Disease
10.10.4 Huntington's Disease
10.10.5 Headache Disorders
10.10.6 Stroke
10.10.7 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Invasive Brain Monitoring Device Sales Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Invasive Brain Monitoring Device Sales Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Invasive Brain Monitoring Device Sales Market Size Forecast by Type
11.6.1 Electroencephalography (EEG) Devices
11.6.2 Magnetoencephalography (MEG) Devices
11.6.3 Transcranial Doppler (TCD) Devices
11.6.4 Intracranial Pressure (ICP) Monitors
11.6.5 Cerebral Oximeters
11.6.6 Magnetic Resonance Imaging (MRI) Devices
11.6.7 Computerized Tomography (CT) Devices
11.6.8 Positron Emission Tomography (PET) Devices
11.6.9 Sleep Monitoring Devices
11.6.10 Electromyography (EMG) Devices
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Invasive Brain Monitoring Device Sales Market Size Forecast by Applications
11.10.1 Epilepsy
11.10.2 Dementia
11.10.3 Parkinson’s Disease
11.10.4 Huntington's Disease
11.10.5 Headache Disorders
11.10.6 Stroke
11.10.7 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Invasive Brain Monitoring Device Sales Analysis and Forecast
12.1 Introduction
12.2 Latin America Invasive Brain Monitoring Device Sales Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Invasive Brain Monitoring Device Sales Market Size Forecast by Type
12.6.1 Electroencephalography (EEG) Devices
12.6.2 Magnetoencephalography (MEG) Devices
12.6.3 Transcranial Doppler (TCD) Devices
12.6.4 Intracranial Pressure (ICP) Monitors
12.6.5 Cerebral Oximeters
12.6.6 Magnetic Resonance Imaging (MRI) Devices
12.6.7 Computerized Tomography (CT) Devices
12.6.8 Positron Emission Tomography (PET) Devices
12.6.9 Sleep Monitoring Devices
12.6.10 Electromyography (EMG) Devices
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Invasive Brain Monitoring Device Sales Market Size Forecast by Applications
12.10.1 Epilepsy
12.10.2 Dementia
12.10.3 Parkinson’s Disease
12.10.4 Huntington's Disease
12.10.5 Headache Disorders
12.10.6 Stroke
12.10.7 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Invasive Brain Monitoring Device Sales Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Invasive Brain Monitoring Device Sales Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Invasive Brain Monitoring Device Sales Market Size Forecast by Type
13.6.1 Electroencephalography (EEG) Devices
13.6.2 Magnetoencephalography (MEG) Devices
13.6.3 Transcranial Doppler (TCD) Devices
13.6.4 Intracranial Pressure (ICP) Monitors
13.6.5 Cerebral Oximeters
13.6.6 Magnetic Resonance Imaging (MRI) Devices
13.6.7 Computerized Tomography (CT) Devices
13.6.8 Positron Emission Tomography (PET) Devices
13.6.9 Sleep Monitoring Devices
13.6.10 Electromyography (EMG) Devices
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Invasive Brain Monitoring Device Sales Market Size Forecast by Applications
13.10.1 Epilepsy
13.10.2 Dementia
13.10.3 Parkinson’s Disease
13.10.4 Huntington's Disease
13.10.5 Headache Disorders
13.10.6 Stroke
13.10.7 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Invasive Brain Monitoring Device Sales Market: Competitive Dashboard
14.2 Global Invasive Brain Monitoring Device Sales Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Natus Medical Inc (US)
14.3.2 Nihon Kohden Corporation (Japan)
14.3.3 Philips Healthcare (Netherlands)
14.3.4 GE Healthcare (U.K.)
14.3.5 Siemens Healthineers (Germany)
14.3.6 Compumedics Ltd. (Australia)
14.3.7 Electrical Geodesics Incorporated (US)
14.3.8 Medtronic plc (Ireland)
14.3.9 CAS Medical Systems, Inc (US)
14.3.10 Advanced Brain Monitoring (US)
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Invasive Brain Monitoring Device Sales Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Invasive Brain Monitoring Device Sales Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Invasive Brain Monitoring Device Sales Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Invasive Brain Monitoring Device Sales Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Invasive Brain Monitoring Device Sales Market Size & Forecast, 2018-2028
4.5.1 Invasive Brain Monitoring Device Sales Market Size and Y-o-Y Growth
4.5.2 Invasive Brain Monitoring Device Sales Market Absolute $ Opportunity
Chapter 5 Global Invasive Brain Monitoring Device Sales Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Invasive Brain Monitoring Device Sales Market Size Forecast by Type
5.2.1 Electroencephalography (EEG) Devices
5.2.2 Magnetoencephalography (MEG) Devices
5.2.3 Transcranial Doppler (TCD) Devices
5.2.4 Intracranial Pressure (ICP) Monitors
5.2.5 Cerebral Oximeters
5.2.6 Magnetic Resonance Imaging (MRI) Devices
5.2.7 Computerized Tomography (CT) Devices
5.2.8 Positron Emission Tomography (PET) Devices
5.2.9 Sleep Monitoring Devices
5.2.10 Electromyography (EMG) Devices
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Invasive Brain Monitoring Device Sales Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Invasive Brain Monitoring Device Sales Market Size Forecast by Applications
6.2.1 Epilepsy
6.2.2 Dementia
6.2.3 Parkinson’s Disease
6.2.4 Huntington's Disease
6.2.5 Headache Disorders
6.2.6 Stroke
6.2.7 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Invasive Brain Monitoring Device Sales Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Invasive Brain Monitoring Device Sales Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Invasive Brain Monitoring Device Sales Analysis and Forecast
9.1 Introduction
9.2 North America Invasive Brain Monitoring Device Sales Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Invasive Brain Monitoring Device Sales Market Size Forecast by Type
9.6.1 Electroencephalography (EEG) Devices
9.6.2 Magnetoencephalography (MEG) Devices
9.6.3 Transcranial Doppler (TCD) Devices
9.6.4 Intracranial Pressure (ICP) Monitors
9.6.5 Cerebral Oximeters
9.6.6 Magnetic Resonance Imaging (MRI) Devices
9.6.7 Computerized Tomography (CT) Devices
9.6.8 Positron Emission Tomography (PET) Devices
9.6.9 Sleep Monitoring Devices
9.6.10 Electromyography (EMG) Devices
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Invasive Brain Monitoring Device Sales Market Size Forecast by Applications
9.10.1 Epilepsy
9.10.2 Dementia
9.10.3 Parkinson’s Disease
9.10.4 Huntington's Disease
9.10.5 Headache Disorders
9.10.6 Stroke
9.10.7 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Invasive Brain Monitoring Device Sales Analysis and Forecast
10.1 Introduction
10.2 Europe Invasive Brain Monitoring Device Sales Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Invasive Brain Monitoring Device Sales Market Size Forecast by Type
10.6.1 Electroencephalography (EEG) Devices
10.6.2 Magnetoencephalography (MEG) Devices
10.6.3 Transcranial Doppler (TCD) Devices
10.6.4 Intracranial Pressure (ICP) Monitors
10.6.5 Cerebral Oximeters
10.6.6 Magnetic Resonance Imaging (MRI) Devices
10.6.7 Computerized Tomography (CT) Devices
10.6.8 Positron Emission Tomography (PET) Devices
10.6.9 Sleep Monitoring Devices
10.6.10 Electromyography (EMG) Devices
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Invasive Brain Monitoring Device Sales Market Size Forecast by Applications
10.10.1 Epilepsy
10.10.2 Dementia
10.10.3 Parkinson’s Disease
10.10.4 Huntington's Disease
10.10.5 Headache Disorders
10.10.6 Stroke
10.10.7 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Invasive Brain Monitoring Device Sales Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Invasive Brain Monitoring Device Sales Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Invasive Brain Monitoring Device Sales Market Size Forecast by Type
11.6.1 Electroencephalography (EEG) Devices
11.6.2 Magnetoencephalography (MEG) Devices
11.6.3 Transcranial Doppler (TCD) Devices
11.6.4 Intracranial Pressure (ICP) Monitors
11.6.5 Cerebral Oximeters
11.6.6 Magnetic Resonance Imaging (MRI) Devices
11.6.7 Computerized Tomography (CT) Devices
11.6.8 Positron Emission Tomography (PET) Devices
11.6.9 Sleep Monitoring Devices
11.6.10 Electromyography (EMG) Devices
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Invasive Brain Monitoring Device Sales Market Size Forecast by Applications
11.10.1 Epilepsy
11.10.2 Dementia
11.10.3 Parkinson’s Disease
11.10.4 Huntington's Disease
11.10.5 Headache Disorders
11.10.6 Stroke
11.10.7 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Invasive Brain Monitoring Device Sales Analysis and Forecast
12.1 Introduction
12.2 Latin America Invasive Brain Monitoring Device Sales Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Invasive Brain Monitoring Device Sales Market Size Forecast by Type
12.6.1 Electroencephalography (EEG) Devices
12.6.2 Magnetoencephalography (MEG) Devices
12.6.3 Transcranial Doppler (TCD) Devices
12.6.4 Intracranial Pressure (ICP) Monitors
12.6.5 Cerebral Oximeters
12.6.6 Magnetic Resonance Imaging (MRI) Devices
12.6.7 Computerized Tomography (CT) Devices
12.6.8 Positron Emission Tomography (PET) Devices
12.6.9 Sleep Monitoring Devices
12.6.10 Electromyography (EMG) Devices
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Invasive Brain Monitoring Device Sales Market Size Forecast by Applications
12.10.1 Epilepsy
12.10.2 Dementia
12.10.3 Parkinson’s Disease
12.10.4 Huntington's Disease
12.10.5 Headache Disorders
12.10.6 Stroke
12.10.7 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Invasive Brain Monitoring Device Sales Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Invasive Brain Monitoring Device Sales Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Invasive Brain Monitoring Device Sales Market Size Forecast by Type
13.6.1 Electroencephalography (EEG) Devices
13.6.2 Magnetoencephalography (MEG) Devices
13.6.3 Transcranial Doppler (TCD) Devices
13.6.4 Intracranial Pressure (ICP) Monitors
13.6.5 Cerebral Oximeters
13.6.6 Magnetic Resonance Imaging (MRI) Devices
13.6.7 Computerized Tomography (CT) Devices
13.6.8 Positron Emission Tomography (PET) Devices
13.6.9 Sleep Monitoring Devices
13.6.10 Electromyography (EMG) Devices
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Invasive Brain Monitoring Device Sales Market Size Forecast by Applications
13.10.1 Epilepsy
13.10.2 Dementia
13.10.3 Parkinson’s Disease
13.10.4 Huntington's Disease
13.10.5 Headache Disorders
13.10.6 Stroke
13.10.7 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Invasive Brain Monitoring Device Sales Market: Competitive Dashboard
14.2 Global Invasive Brain Monitoring Device Sales Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Natus Medical Inc (US)
14.3.2 Nihon Kohden Corporation (Japan)
14.3.3 Philips Healthcare (Netherlands)
14.3.4 GE Healthcare (U.K.)
14.3.5 Siemens Healthineers (Germany)
14.3.6 Compumedics Ltd. (Australia)
14.3.7 Electrical Geodesics Incorporated (US)
14.3.8 Medtronic plc (Ireland)
14.3.9 CAS Medical Systems, Inc (US)
14.3.10 Advanced Brain Monitoring (US)
Segments Covered in the Report
The global Invasive Brain Monitoring Device Sales market has been segmented based on
By Types
The global Invasive Brain Monitoring Device Sales market has been segmented based on
By Types
- Electroencephalography (EEG) Devices
- Magnetoencephalography (MEG) Devices
- Transcranial Doppler (TCD) Devices
- Intracranial Pressure (ICP) Monitors
- Cerebral Oximeters
- Magnetic Resonance Imaging (MRI) Devices
- Computerized Tomography (CT) Devices
- Positron Emission Tomography (PET) Devices
- Sleep Monitoring Devices
- Electromyography (EMG) Devices
- Epilepsy
- Dementia
- Parkinson’s Disease
- Huntington's Disease
- Headache Disorders
- Stroke
- Others
- Asia Pacific
- North America
- Latin America
- Europe
- Middle East & Africa
- Natus Medical Inc (US)
- Nihon Kohden Corporation (Japan)
- Philips Healthcare (Netherlands)
- GE Healthcare (U.K.)
- Siemens Healthineers (Germany)
- Compumedics Ltd. (Australia)
- Electrical Geodesics Incorporated (US)
- Medtronic plc (Ireland)
- CAS Medical Systems, Inc (US)
- Advanced Brain Monitoring (US)
Our Clients
Related Reports
Some other reports from this category!
